Clinical Trials Directory

Trials / Completed

CompletedNCT05919966

The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units

The Association Between Chlorhexidine Bathing Every Other Day and Central Line-Associated Infections in Medical Intensive Care Units: An Observational Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
6,930 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We conducted a retrospective observational cohort study assessing the relationship between regular bathing using 2% CHG wipes every other day and the occurrence of central line-associated infections (CLABSI) in patients within the medical intensive care unit (MICU).

Detailed description

This study defined the post-intervention period as July 1, 2017, to June 30, 2022. During this period, one of the three medical intensive care units (MICUs) in NTUH implemented chlorhexidine gluconate (CHG) bathing as part of their daily care routine (CHG group). This decision was made in response to a higher incidence rate of vancomycin-resistant Enterococcus (VRE) bacteremia observed in that particular MICU during the preceding six months (pre-intervention period: January 1, 2017, to June 30, 2017), compared to the other two MICUs. The remaining two MICUs continued to provide usual care, which involved bathing patients with towels soaked in water and soap on a daily basis.

Conditions

Interventions

TypeNameDescription
OTHERChlorhexidine bathingThe procedure involved pouring an entire bottle (200ml) of 2% CHG solution (PBF Biotech, Taipei, Taiwan) onto a pre-packed set of eight single-use cotton wipes before each bathing session. A minimum of six wipes were required to thoroughly cover the entire body, including the bilateral upper and lower extremities, front and back of the trunk, perineum, and buttocks.

Timeline

Start date
2023-04-12
Primary completion
2023-04-30
Completion
2023-05-30
First posted
2023-06-27
Last updated
2023-06-27

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05919966. Inclusion in this directory is not an endorsement.